This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast&utm_campaign=CTA_1">theimmunooncologycurve.substack.com</a>

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit theimmunooncologycurve.substack.com

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast&amp;utm_campaign=CTA_1" rel="noopener noreferrer">theimmunooncologycurve.substack.com</a>

Episode 1: Sending the Immune System Back to School Against Cancer

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast">theimmunooncologycurve.substack.com</a>

Science

Medicine

Health & Fitness

Life Sciences

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. theimmunooncologycurve.substack.com

A podcast on next-generation immunotherapy developments against cancer. The Immuno-Oncology Curve is produced by Agenus, a clinical-stage biopharmaceutical company that discovers and develops immunotherapies for cancer. Dr. O’Day is the company’s Chief Medical Officer. Occasionally, guests on the podcast will be paid advisors to Agenus or represent organizations that receive funding from Agenus. <a href="https://theimmunooncologycurve.substack.com?utm_medium=podcast" rel="noopener noreferrer">theimmunooncologycurve.substack.com</a>

Share Episode 1: Sending the Immune System Back to School Against Cancer

Sign up to save your podcasts

Episode 1: Sending the Immune System Back to School Against Cancer

Episode 1: Sending the Immune System Back to School Against Cancer